|
EFTR
|
eFFECTOR Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
SLS
|
SELLAS Life Sciences Group, Inc.
|
US
|
NASDAQ
|
|
PRRUF
|
Immutep Ltd
|
US
|
OTC
|
|
BGBIO
|
Bergenbio ASA
|
NO
|
OL
|
|
ALTME
|
TME Pharma N.V.
|
FR
|
PA
|
|
BLRX
|
BioLine RX Ltd
|
IL
|
TA
|
|
KANT
|
Kineta, Inc.
|
US
|
US
|
|
2AB
|
VACCITECH (SP.ADR)/1
|
DE
|
F
|
|
4PKB
|
LAVA THERAP. B.V. EO-12
|
DE
|
F
|
|
5LB
|
BIOVAXYS TECHNOLOGY CORP.
|
DE
|
F
|
|
6C1
|
CytomX Therapeutics Inc
|
DE
|
F
|
|
BIX0
|
BIOINVENT INTERN. SK 2
|
DE
|
F
|
|
BRM
|
Bristol-Myers Squibb Company
|
DE
|
F
|
|
H7T1
|
HUTCHMED (China) Limited
|
DE
|
F
|
|
H7T2
|
HUTCHMED (CHINA) LS-1
|
DE
|
F
|
|
RXK3
|
SELLAS Life Sciences Group Inc
|
DE
|
F
|
|
YP1A
|
Immutep Limited
|
DE
|
F
|
|
YP1B
|
Immutep Limited
|
DE
|
F
|
|
0QAH
|
Merck & Company Inc
|
GB
|
IL
|